Signal active
Investment Firm
Overview
Aberdare Ventures is a venture firm that focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies. They limit their commitments in the belief that their involvement can increase the probability of success for their portfolio companies and generate greater returns for their investors.
Highlights
1999
Venture Capital
11-50
72
7
22
Late Stage Venture, Early Stage Venture, Seed, Private Equity
Venture Capital
Location
San Francisco, California, United States, North America
Contact Information
Social
Profile Resume
Aberdare Ventures, established in 1999 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Biotechnology, Health Care, Pharmaceutical, Financial Services, Venture Capital, Finance, Consumer, Medical, Fitness, Health Diagnostics. The organization boasts a portfolio of 72 investments, with an average round size of $20.2M and 22 successful exits. Their recent investments include Anacor Pharmaceutical, Rho Capital Partners, Venrock, Care Capital, GSK. The highest investment round they participated in was $105.7B. Among their most notable exits are Anacor Pharmaceutical and Rho Capital Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
72
9
7
22
Investments
72
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jun 25, 2015 | Realeve | Health Care | 43.2M |
Jul 19, 2017 | Gravia | Wholesale | 14.1M |
Aug 20, 2018 | MC10 | Semiconductor | 10.0M |
Sep 05, 2018 | Cricket Health | Health Care | 24.0M |
Exits
22
Funding Timeline
72
0
1
Funding Rounds
72
Aberdare Ventures has raised 72 rounds. Their latest funding was raised on Sep 05, 2018 from a Series A - Cricket Health round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jun 25, 2015 | Series D - Realeve | - | 43.2M | - |
Jul 19, 2017 | Series C - Gravia | - | 14.1M | - |
Aug 20, 2018 | Venture Round - MC10 | - | 10.0M | - |
Sep 05, 2018 | Series A - Cricket Health | - | 24.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
Funding Round
Sep 05, 2018
Cricket Health raised $24000000 on 2018-09-05 in Series A
Funding Round
Aug 20, 2018
MC10 raised $10028000 on 2018-08-20 in Venture Round
Funding Round
Jul 19, 2017
Gravia raised $14100000 on 2017-07-19 in Series C
Funding Round
Jun 25, 2015
Realeve raised $43200000 on 2015-06-25 in Series D
Funding Round
May 21, 2015
Jiff raised $23300000 on 2015-05-21 in Series C